Prevalence and predictors of periconceptional folic acid uptake--prospective cohort study in an Irish urban obstetric population.
AffiliationCoombe Women and Infants University Hospital, Dolphins Barn, Dublin 8, Ireland.
Folic Acid/administration & dosage/*metabolism
Neural Tube Defects/*epidemiology
MetadataShow full item record
CitationHum Reprod. 2010 Feb;25(2):535-43. Epub 2009 Nov 12.
JournalHuman reproduction (Oxford, England)
AbstractBACKGROUND: Neural tube defects (NTDs) are severe abnormalities of the central nervous system that occur as a result of abnormal development in the third and fourth weeks of gestation. Studies have shown that periconceptional folic acid (FA) can reduce both the incidence and recurrence of NTDs. METHODS: A cohort study was carried out using the electronic hospital booking records of women delivering in a large Dublin maternity hospital between 2000 and 2007. Logistic regression analyses were performed to measure the associations between maternal factors and optimal FA use. RESULTS: Of the 61,252 women in the cohort, 85% reported taking FA at some point during the periconceptional period; however, only 28% took FA as recommended. Factors associated with taking the recommended amount of FA included nulliparity [adjusted OR: 1.35 (95% CI: 1.28-1.43)], early booking (<12 weeks) [OR: 1.24 (95% CI: 1.17-1.31)], increasing maternal age (e.g. 30-34 years) [OR: 1.39 (95% CI: 1.30-1.48)], private health care [OR: 4.32 (95% CI: 4.1-4.6)] and fertility treatment [OR: 2.88 (95% CI: 2.44-3.40)]. Factors associated with taking less than recommended or no FA included unplanned pregnancy [OR: 0.08 (0.07-0.08)], lower socio-economic status (e.g. unemployed) [OR: 0.63 (95% CI: 0.55-0.71)], non-Irish nationality [OR: 0.82 (0.74-0.90)] and smokers [OR: 0.51 (95% CI: 0.47-0.55)]. CONCLUSIONS: Social, demographic and economic factors have an important influence on the FA uptake. Vulnerable groups who report limited uptake of FA need to be specifically targeted in future Public Health campaigns and further consideration needs to be given to the debate on food fortification in countries where this is currently not available.
- Awareness and use of folic acid, and blood folate concentrations among pregnant women in northern China--an area with a high prevalence of neural tube defects.
- Authors: Ren A, Zhang L, Li Z, Hao L, Tian Y, Li Z
- Issue date: 2006 Oct
- The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia.
- Authors: Forster DA, Wills G, Denning A, Bolger M
- Issue date: 2009 Apr
- Promotion of folate for the prevention of neural tube defects: who benefits?
- Authors: Bower C, Miller M, Payne J, Serna P
- Issue date: 2005 Nov
- Preventing neural tube defects in Europe: a missed opportunity.
- Authors: Busby A, Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, Armstrong N, Baguette A, Barisic I, Berghold A, Bianca S, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit AK, De Walle H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergja R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell R, Neville A, Olars B, Portillo I, Ritvanen A, Robert-Gnansia E, Rösch C, Scarano G, Steinbicker V
- Issue date: 2005 Sep-Oct
- [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
- Authors: Meijer WM, de Walle HE
- Issue date: 2005 Nov 12